We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Rosetta Genomics, Moffitt Cancer Center Enter mRNA-Based Cancer Diagnostic Agreement

News   Jun 10, 2014

 
Rosetta Genomics, Moffitt Cancer Center Enter mRNA-Based Cancer Diagnostic Agreement
 
 
Advertisement
 

RELATED ARTICLES

How A Protein Can Inhibit Cancer Development in Mice

News

Researchers have discovered how the protein PP2A can inhibit tumor growth in mice.

READ MORE

App Calculates Risk of Postponing Cancer Care During COVID-19 Pandemic

News

A team from The University of Michigan has created the "OncCOVID app". This new app draws on global cancer and coronavirus data to create an individualized mortality risk assessment for receiving immediate versus delayed cancer treatment.

READ MORE

A High-resolution 3D View Inside Tumors

News

Researchers have now succeeded in visualizing spatial changes within tumors using optoacoustics. This method could be helpful for the future development of new anticancer drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE